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Abstract
Background: Growth monitoring is an essential part of primary health care in children and short stature is
frequently regarded as a relatively early sign of poor health. The association of short stature and dysmorphic
features should always lead to exclude an underlying syndromic disorder.
Case presentation: We report the case of an Indian school-aged boy with dysmorphic features, intellectual
disability and a clinical history characterized by seizures and hearing problems. Although his height was always
included in the normal range for age and sex throughout childhood, he presented a short near-adult stature in
relation to his mid-parent sex-adjusted target height. This is probably due to a rapidly progressive pubertal
development.
Conclusions: In the presence of characteristic dysmorphic features, intellectual disability, seizures and hearing
problems, KBG syndrome should always be considered. This emergent condition presents a wide spectrum of
clinical phenotypes and is often associated with adult short stature.
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Introduction
Human growth is a very complex phenomenon regulated
by genetic, hormonal, nutritional and environmental fac-
tors. Although it continues from the embryonic life to
puberty and early adulthood, it is a dynamic process
such that normal height at one specific moment does
not exclude the possibility that short stature (SS) appears
later, because of innate or acquired growth disruptors
[1]. Thus, childhood growth monitoring is an essential
part of primary health care in children, and SS must be
regarded as a relatively early sign of poor health [2]. SS
can have a wide variety of causes. Although the GH-IGF
axis has a central role with specific actions on growth,
numerous genes are involved in the control of stature
[3]. Nonetheless, these genes explain only a small frac-
tion of the phenotypic variation in height. Multiple dis-
orders characterized by prenatal and/or postnatal onset
growth failure have been described and, among these,
there are many new syndromes unravelled in the last de-
cades [4, 5]. Consequently, the aim of the endocrinology
evaluation for a child with SS is to investigate the pos-
sible causes of his condition with particular focus on
possible syndromic disorders, especially if dysmorphic
features are present.
Case presentation
Here we describe the clinical history of an Indian
school-aged boy. He was born at term in India by emer-
gency C-section, due to prolonged labour after an un-
eventful pregnancy. Birth weight was 2500 g (− 1.95
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standard deviations score [SDS]) and birth length 49 cm
(− 0.50 SDS), for the evaluation of neonatal measures we
used Bertino Neonatal Anthropometric Charts [6]. Par-
ents were not related and had a normal stature (mid-
parent sex-adjusted target height 174.5 cm). No note-
worthy disease was reported in the family history. In the
neonatal period, no complications were described. He
was able to walk alone only at 18 months old. The family
moved to Italy when he was 3 years old without major
clinical problems. When he was 6 years old, during the
first year of school, learning difficulties emerged. Thus,
he was referred to an infant neuropsychiatrist who sub-
mitted him to some investigations. In particular, karyo-
type was normal and the fragile X syndrome was
excluded. A brain MRI showed bilateral diffuse subepen-
dymal heterotopia, partially empty sella and hypoplastic
anterior pituitary. After these findings, he was referred
to a pediatric endocrinology evaluation, which was not
performed.
When he was 7 years old, he underwent adenoidect-
omy for recurrent middle ear infections. Subsequently,
he continued to present numerous episodes of otitis
media, which led to bilateral conductive moderate de-
gree hearing loss. At 9 years of age, after a CT scan of
petrous bones detected chronic erosive otitis and a bilat-
eral tympanic membrane perforation, he underwent bi-
lateral myringoplasty. At 11 years old, he was
hospitalized for a first episode of seizures. Epilepsy was
diagnosed and a specific treatment was started.
He came to our attention for the first time in May
2017, when he was 11 years and 5months old. His height
was 147.9 cm (0.18 SDS) and his weight 34.5 kg (− 0.87
SDS), SDS were derived from Cacciari Italian cross-
sectional growth charts [7]. At our clinical examination,
he appeared in good general conditions, with normal
body proportions, but a moderate psychomotor delay
emerged. Besides, some syndromic features were no-
ticed: macrodontia of the upper central incisors,
synophrys, widely spaced eyes, bushy eyebrows and
bulbous nose (Fig. 1). Genital examination revealed a Ph
3 and a testicular volume of 10 mL bilaterally. A true bi-
lateral gynecomastia was observed. Bone age was ad-
vanced over chronological age by ∼2 years. IGF1 level
was normal (57.03 nmol/L, 1.10 SDS for age and sex).
Thyroid function was normal. Furthermore, we per-
formed a GnRH-analogue test that confirmed a normal
activation of hypothalamus-pituitary-gonads axis and an
ACTH test that excluded late onset congenital adrenal
hyperplasia as cause of bone age advancement. A new
brain MRI confirmed the previous one. Despite we rec-
ommended a follow up every 6 months, he came back to
our attention only 18 months later, when height was
154 cm (− 0.29 SDS), weight 39.1 kg (− 1.10 SDS) and
pubertal development was complete. Thyroid, adrenal
and gonadal functions remained normal. Bone age was
16 years and 6months (versus a chronological age of 13
years). His height was in the normal range for chrono-
logical age; however, considering his complete pubertal
development and his bone age, his prediction of adult
height according to Byley and Pinneau tables was only
157.5 cm (Fig. 2). Considering his dysmorphic features
and his SS, we decided to further investigate the case in
the suspect of Cornelia De Lange syndrome. Next-
generation sequencing (NGS) panel analysis was per-
formed and a de novo variant heterozygous in exon 9 on
ANKRD11 gene was detected (NC_000016.9:g89351043_
89351047del, NM_013275:c.1903_1907del; with a pre-
dicted protein change p.Lys635GInfs*26). This mutation
is causative of KBG syndrome [8, 9]. Therefore, clinical
and anamnestic characteristics of our patient led us to
diagnose KBG syndrome, which is an emergent condi-
tion with a wide spectrum of clinical phenotypes, often
associated with adult short stature. Once the definitive
diagnosis was obtained, in order to define the extent of
disease and needs of our patient, he was subjected to
complete and multidisciplinary evaluations aimed at
Fig. 1 Pictures of our patient are represented
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identifying the most common anomalies present in the
KBG syndrome. In particular, cardiological and ocular
abnormalities were excluded; a class II malocclusion was
evidenced and a large right tympanic perforation was di-
agnosed, for which surgery was necessary.
The study was conducted in compliance with the
terms of the Helsinki II Declaration. Written informed
consent was obtained from the patient’s parents for pub-
lication of this case report and any accompanying im-
ages. In our country, namely Italy, this type of clinical
study does not require Institutional Review Board/Insti-
tutional Ethics Committee approval to publish the
results.
Discussion and conclusions
KBG syndrome is a rare autosomal dominant disorder
with multiple congenital anomalies and intellectual dis-
ability. The disorder was first described in 1975 as a new
“malformation/retardation syndrome” in three families;
consequently, its name derives from the initials of the
last names of three original families diagnosed with this
syndrome [10]. KBG syndrome was initially thought to
be quite rare; however, it is likely underdiagnosed be-
cause many of its features are often mild and non-
specific, and none of them are a prerequisite for the
diagnosis [11]. To date, almost 200 subjects affected by
the syndrome have been reported [12]. Although several
familiar cases have been described, most of the affected
individuals have novel de novo mutations. It is worth
mentioning that there is significant variability in the
clinical findings, even between affected members of the
same family and frequently, a mildly affected mother is
recognized only after a typically affected son is diag-
nosed [13].
KBG syndrome should be suspected in an individual
with developmental delay/cognitive impairment or sig-
nificant behavioral issues in association with other fea-
tures such as distinctive craniofacial characteristics, SS
and skeletal anomalies. Eight major clinical criteria were
initially defined: macrodontia of the upper central per-
manent incisors (which is reported in 85–95% of af-
fected individuals), characteristic facial appearance, hand
anomalies, neurological involvement, delayed bone age,
costovertebral anomalies, SS, and the presence of a first-
degree relative with KBG syndrome [8]. Afterwards, de-
layed bone age and costovertebral anomalies were sug-
gested to be removed, and macrodontia was not
considered a mandatory criterion any longer [12–16].
Fig. 2 The growth chart of our patient is represented
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Minor features that can further help to establish a clin-
ical diagnosis are otitis media and hearing impairment,
seizures, cryptorchidism, feeding problems, palatal insuf-
ficiency, and delayed anterior fontanelle closure [14].
However, no consensus clinical diagnostic criteria for
KBG syndrome have yet been published.
Our patient presented with a typical subset of clinical
(such as macrodontia of the upper central incisors,
synophrys, widely spaced eyes, bushy eyebrows and
bulbous nose) and anamnestic (such as neuro-
developmental delay, seizures and otitis media) charac-
teristics of KBG syndrome; nevertheless, we initially hy-
pothesized a Cornelia de Lange syndrome. The clinical
signs that made us suspect this syndrome were SS, intel-
lectual disability, seizures, craniofacial abnormalities, in
particular synophyrys and hirsutism. Mild Cornelia de
Lange syndrome, in fact, shares many findings with KBG
syndrome; however, patients tend to have smaller head
circumference and greater degrees of intellectual disabil-
ity [17, 18]. The clinical presentation of Cornelia de
Lange syndrome has a very wide spectrum and can
closely resemble other genetic disorders, especially in
non-classical phenotypes. Therefore, genetic testing is
recommended to make a definitive diagnose and rule
out other genetic disorders. The first-line molecular
diagnostic approach should be NGS-based screening fo-
cused on NIPBL, SMC1A, SMC3, RAD21, BRD4,
HDAC8, and ANKRD11 genes. According to the first
consensus statement about the diagnosis and the man-
agement of Cornelia de Lange syndrome, this specific
panel is considered the most effective way of detecting
causative variants in all the genes known to cause Cor-
nelia de Lange syndrome [19]. This approach allowed us
to diagnose our patient as affected by KBG syndrome. In
particular, as previous mentioned, a de novo variant het-
erozygous in exon 9 on ANKRD11 gene was detected
(NC_000016.9:g89351043_89351047del, NM_013275:
c.1903_1907del; with a predicted protein change
p.Lys635GInfs*26). Generally, single nucleotide variants
within ANKRD11 gene account for approximately 83%
of pathogenic variants and larger copy number variants
(mostly deletions) involving ANKRD11 gene detectable
by chromosomal microarray account for approximately
17% of cases [15, 18, 20].
The definitive diagnosis of KBG syndrome is rarely
achieved before the upper permanent central incisors
have erupted at age 7–8 years [13]. Nevertheless, focus-
ing on all the dysmorphic features is key to anticipate
the age of definitive diagnosis. In this way, patients could
benefit from early multidisciplinary interventions allow-
ing better outcomes, especially with regards to growth
and neurocognitive performances. Overall, with appro-
priate management, the prognosis of the syndrome is
good [12].
Our patient was sent to our attention after the execu-
tion of brain MRI, which detected subependymal grey
matter heterotopia, partially empty hypoplastic sella tur-
cica and hypoplastic anterior pituitary gland tissue. Al-
though the exact frequency of brain malformations is
not known, several brain abnormalities have been re-
ported in various cohorts of affected individuals [8, 18,
21]. When he was 11 years old, he developed epilepsy
characterized by tonic-clonic seizures associated to EEG
abnormalities; this symptom has been reported in about
50% of affected individuals, with age of onset variable
between infancy and teenage years [14, 22]. In addition
to these neurological abnormalities, he presented with
history of learning difficulties, that required addition aid
to attend mainstream classes, and development delay,
for which he had been followed up for a long time. More
than 90% of patients with KBG syndrome have some de-
gree of developmental delay, especially in speech [20,
22]. Besides neurologic features, another typical anam-
nestic element was the hearing impairment. Our patient
suffered from recurrent episodes of otitis media
throughout the childhood that ended to perforate ear-
drums, requiring bilateral myringoplasty. About 30% of
affected individuals report hearing problems, with con-
ductive loss being the most frequent [18].
Variable skeletal anomalies have been reported in 75%
of individuals affected by KBG syndrome. The most fre-
quent findings are costovertebral anomalies, such as cer-
vical ribs, abnormal vertebral shape, end plate
abnormalities, posterior fusion defects, or spina bifida
occulta [15]. Other anomalies include a short and
webbed neck, abnormal ribs, brachydactyly, clinodactyly,
scoliosis, cardiac defects [20], ocular findings [13], skin
and hair abnormalities [14]. Our patient did not pre-
sented any of the aforementioned anomalies, except for
a clinical hirsutism that could be due to his ethnic
group.
SS is very common among these patients, being found
in 40–77% of affected individuals [20, 23]. At birth, aux-
ological parameters are usually normal, as in our patient,
and only later SS becomes evident. Preliminary evidence
suggests that growth hormone treatment may increase
the height potential of affected subjects [23, 24]. When
our patient came to our attention for the first time, his
height was in the normal range for sex and age (0.18
SDS). He presented clinical signs of intermediate puber-
tal development, confirmed also by serum levels of tes-
tosterone and an advanced bone age of 2 years. After 18
months, his bone age had further advanced, widening
the gap between bone age and chronological age, and,
thus, considerably affecting his final height prediction.
While SS and delayed bone age are frequently related to
KBG syndrome, rapid pubertal development and ad-
vanced bone age are uncommon [12, 18]. By observing
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his growth curve, reconstructed thanks to the data noted
by his paediatrician, what emerged was that his stature
was always included between the normal range for age
and sex throughout childhood, with an abnormal in-
crease in stature between 8 and 11 years. This might be
due to an unidentified precocious puberty, which has
been already described in children with KBG syndrome
[20]. A premature activation of puberty may reason-
ably explain the rapid advancement in bone matur-
ation and be one of the main causes of his short
final stature. If precocious puberty had been
promptly identified and treated with GnRH-
analogous, the slowdown in puberty development
would have perhaps allowed an increase in our pa-
tient’s growth potential [12]. Considering that for
male adults affected by KBG syndrome is reported a
mean stature of 153.6 cm [13], we could say that the
current height of our patient is included in the nor-
mal range. However, it is reduced in relation to his
mid-parent sex-adjusted target height. Furthermore,
contrary to what happens in the majority of individ-
uals affected by the syndrome, our patient did not
show a spontaneous catch-up growth between child-
hood and adulthood [23].
This case report offers some insights. First, the link be-
tween dysmorphic features, SS, and intellectual disability
confirms to be a common red flag for syndromic dis-
order. We recommend to investigate the clinical hypoth-
esis of KBG when a child presents dysmorphic features,
even of mild degree, regardless of the presence of SS, be-
cause normal height at one specific time during child-
hood does not exclude the possibility of SS occurring
later in development. Second, the NGS approach reveals
to be extremely useful in the diagnostic process. In pres-
ence of clinical suspicion of syndromic disorder, we sug-
gest proceeding as soon as possible with pediatric
genetic evaluation and/or genetic analysis with NGS ap-
proach, in order to reach the correct diagnosis and to es-
tablish the most appropriate treatment and follow up.
In conclusion, in the presence of dysmorphic features,
intellectual disability, and a clinical history characterized
by seizures and hearing problems, KBG syndrome
should always be considered and excluded. This emer-
gent condition presents a wide spectrum of clinical phe-
notypes and is often associated with adult SS.
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